Seminario: "Targeted Protein Degradation: advancing degraders as a novel therapeutic modality"

Guido Papa (University of Cambridge):
"Targeted Protein Degradation: advancing degraders as a novel therapeutic modality".

Il seminario fa parte del corso Human Health and Disease organizzato per il dottorato GBMC, ma siete tutti benvenuti.